Wei Lin
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Blood properties and coagulation, Diabetes, Cardiovascular Risks, and Lipoproteins, Tuberculosis Research and Epidemiology, Microfluidic and Capillary Electrophoresis Applications
Most-Cited Works
- → Genetic and functional evidence links a missense variant in B4GALT1 to lower LDL and fibrinogen(2021)30 cited
- → Design and optimization of porous polymer enzymatic digestors for proteomics(2009)21 cited
- → Genetic and functional evidence relates a missense variant in B4GALT1 to lower LDL-C and fibrinogen(2019)4 cited
- → A Precipitation-Based Process to Generate a Solid Formulation of a Therapeutic Monoclonal Antibody: An Alternative to Lyophilization(2025)2 cited
- The levels of Il-6,IL-10,TNF detected by cytometric bead array during acute leukemia(2008)
- → Variants in TLR6 Gene Influence Susceptibility to Tuberculosis in the Chinese Population(2020)